SIG
LLY icon

Stanford Investment Group’s Eli Lilly LLY Stock Holding History

Stanford Investment Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-145
Closed -$12K – 366
2015
Q4 		$12K Buy
+145
New +$12K 0.01% 258

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stanford Investment Group's LLY Position: Q1 2016 in Review

Stanford Investment Group sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 145 shares — an estimated $12K sold.

Stanford Investment Group first reported a position in LLY in Q4 2015 and held it in 1 quarter. The position peaked at $12K in Q4 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Stanford Investment Group reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • Stanford Investment Group sold 145 Eli Lilly shares in Q1 2016, an estimated $12K.
  • Stanford Investment Group first reported a position in Eli Lilly in Q4 2015 and held it in 1 quarter.
  • Stanford Investment Group's Eli Lilly position peaked at $12K in Q4 2015.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Stanford Investment Group's 13F filing for Q1 2016, filed 10 Nov 2016.